Cover Image
市場調查報告書

顱內動脈瘤破裂導致蜘蛛膜下腔出血:全球臨床實驗檢討

Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 226832
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
顱內動脈瘤破裂導致蜘蛛膜下腔出血:全球臨床實驗檢討 Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014
出版日期: 2014年05月21日 內容資訊: 英文 75 Pages
簡介

本報告提供顱內動脈瘤破裂導致蜘蛛膜下腔出血相關的臨床研究最新趨勢分析,提供疾病·治療方法概要,及主要已開發國家·新興國家的臨床實驗狀況,各地區、各階段的進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑等資訊,為您概述為以下內容。

目錄

簡介

  • 顱內動脈瘤破裂導致蜘蛛膜下腔出血
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的前五名國家
    • 歐洲的前五名國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國臨床實驗數量:中樞神經系統疾病臨床實驗整體中顱內動脈瘤破裂導致蜘蛛膜下腔出血的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病臨床實驗整體中顱內動脈瘤破裂導致蜘蛛膜下腔出血的比例

E7各國臨床實驗數量:Phase別

E7各國臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

  • 參加顱內動脈瘤破裂導致蜘蛛膜下腔出血治療藥臨床實驗的前幾名企業

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Actelion Ltd
    • Edge Therapeutics, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Vanderbilt University
    • Chinese University of Hong Kong
    • Kuopio University Hospital
    • University of Cambridge
    • Charite - Universitatsmedizin Berlin
    • Utrecht University
    • Oslo University Hospital
    • Rigshospitalet
    • University of Miami
    • University of Calgary

5個有代表性的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2152CTIDB

GlobalData's clinical trial report, "Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014" provides data on the Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aneurysmal Subarachnoid Hemorrhage (SAH). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aneurysmal Subarachnoid Hemorrhage (SAH). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Aneurysmal Subarachnoid Hemorrhage (SAH)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Aneurysmal Subarachnoid Hemorrhage (SAH)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Actelion Ltd
      • Clinical Trial Overview of Actelion Ltd
      • Edge Therapeutics, Inc.
      • Clinical Trial Overview of Edge Therapeutics, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Kuopio University Hospital
      • Clinical Trial Overview of Kuopio University Hospital
      • University of Cambridge
      • Clinical Trial Overview of University of Cambridge
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • Utrecht University
      • Clinical Trial Overview of Utrecht University
      • Oslo University Hospital
      • Clinical Trial Overview of Oslo University Hospital
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • University of Miami
      • Clinical Trial Overview of University of Miami
      • University of Calgary
      • Clinical Trial Overview of University of Calgary
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cambridge, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht University, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2014*

List of Figures

  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top